Quarterly report pursuant to sections 13 or 15(d)

Income Taxes

v2.4.0.6
Income Taxes
9 Months Ended
Mar. 31, 2013
Income Tax Disclosure [Abstract]  
Income Tax Disclosure [Text Block]

Note 9 Income Taxes

 

As of March 31, 2013, AntriaBio provided a full valuation allowance against deferred tax assets based on the weight of the available evidence, both positive and negative, including AntriaBio’s operating losses, which indicate that it is more likely than not that such benefits will not be realized.